ArticleRMD open2017

Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis.

Inês Pedro Perpétuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.